Alicia Gallegos

As journal’s retraction count nears 170, it enhances vetting

A journal is implementing tighter controls for guest editors and peer reviewers after an investigation led to the retraction of more than 160 articles.

As we reported last month, the American Society For Testing And Materials (ASTM) International started an investigation into its Journal of Testing and Evaluation after an ASTM vendor noticed some “irregular patterns in the peer review” of a special issue. The investigation revealed the peer review process in four special sections or issues had been compromised, resulting in the retraction of 147 articles.

The journal has since pulled 19 more papers, this time from a special section on human-centered artificial intelligence published in 2021.

Court challenge could chill reporting of research fraud, say whistleblower attorneys

The U.S. government recently announced a record $6.8 billion in False Claims Act settlements and judgments in 2025, the most in a single year since the law’s enactment 163 years ago. For those concerned with scientific integrity, another significant FCA record was also set in 2025: the number of suits brought under the FCA by private individuals against entities they believe defrauded the federal government.

Successful qui tam suits brought under the FCA can come with incentivizing monetary rewards – sometimes substantial – for the whistleblowers. Whistleblowers filed a record 1,297 of these so-called qui tam lawsuits in 2025, up from 979 suits in 2024.

Despite the FCA’s banner year, legal experts say a pending challenge may weaken the law’s whistleblower power and impact. A Florida district court recently struck down the FCA’s qui tam provisions as unconstitutional because these suits involve individuals suing on behalf of the government. If an appeals court upholds the decision, some whistleblowers in that court’s jurisdiction may no longer get paid for exposing wrongdoing, a change that could allow more fraud to slip under the radar, legal analysts say.

U.S. ORI’s first finding of 2026: Researcher faked data in grant apps

A former cancer researcher at University of Oklahoma Health Science Center has been barred from participating in federally funded research without supervision for three years after the U.S. Office of Research Integrity found he falsified data in grant applications.

Daniel Andrade committed research misconduct by falsifying data in two grant applications, according to a summary published Feb. 6 on the ORI website and to be published in the Federal Register. The finding is the agency’s first in 2026 and follows just two findings in 2025.

Now a scientist at Cytovance Biologics, according to LinkedIn, Andrade did not return messages seeking comment. ORI also did not get back to us.

Spanish court rules researcher plagiarized colleague, orders withdrawal of works

Spain’s Supreme Court in Madrid
*Cberbell/Wikimedia Commons*

The Supreme Court of Spain has ordered a literary scholar to pursue retractions of nine works it determined were plagiarized.

The Tribunal Supremo upheld a lower court’s ruling that narrative theory researcher Franciscó Álamo Felices, a professor at the University of Almería in Spain, plagiarized a colleague’s work in two books and seven articles. José R. Valles Calatrava, a literary theory professor at the same university, sued Felices in 2019 for infringement of his intellectual property rights.

That lower court found Felices responsible for “a huge amount of plagiarism at different times and in different articles, revealing a systematic and conscientious parasitic attitude and a desire for appropriation,” according to a translation of the ruling by DeepL Translate. In an October 2025 decision, the Tribunal Supremo dismissed an appeal by Felices against the ruling, finding he failed to demonstrate any fundamental errors of law.

Journal retracts nearly 150 articles for compromised peer review

A journal published by an organization that develops technical standards is retracting 147 papers for problematic peer review — and the publisher expects more to follow.

The American Society For Testing And Materials (ASTM) International started an investigation into its Journal of Testing and Evaluation after an ASTM vendor noticed some “irregular patterns in the peer review” in a special issue, spokesperson Gavin O’Reilly told Retraction Watch. When the publisher confirmed those patterns, ASTM decided to investigate several related issues, he said.

The investigation revealed the peer review process in the special sections or issues had been compromised, each of the retraction notices says.

Lawsuit fails to block retraction of paper claiming to link heart-related deaths to COVID-19 vaccines

*Greg J. Marchand in a photo from his research institute’s website.*

A Taylor & Francis journal has retracted a widely-read paper linking cardiac-related mortality to COVID-19 vaccines after an unsuccessful legal attempt by the lead author to block the withdrawal. That author says he is considering further legal action against the publisher.

The article, “Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-analysis of self-controlled case series studies,” drew swift criticism when it was published in Human Vaccines & Immunotherapeutics in August 2023. At the time, critics and sleuths were quick to challenge the data and methods used in the paper, which now has more than 143,000 views on the Taylor & Francis website and has been cited 15 times, including by two letters to the editor of the journal and a response from the authors, according to Clarivate’s Web of Science.

The retraction notice, posted online January 16, states the retraction resulted from concerns that arose about the methodology of the study and the integrity and availability of the data. The authors provided a full response to the queries; however, the publisher determined the validity of the findings remained in question, the notice states. It continues:

Fed up, author issues her own retraction after journal ghosts her

At wit’s end after a publisher ignored her repeated requests for a correction, Ursula Bellut-Staeck took the extreme step of issuing her own retraction. But is that even a thing?

Bellut-Staeck, an independent researcher from Berlin, Germany, submitted a paper to SCIREA Journal of Clinical Medicine last spring after receiving an invitation from the journal. The article, about mechanotransduction and the impact of infrasound and vibrations, was published June 16.

But when Bellut-Staeck realized her affiliation as listed on the article needed changing, she contacted the journal to request a correction. The problem, she said, was linguistic. Because she didn’t realize “affiliation” has a different meaning in German than English, she had mistakenly listed herself as being at an institution she has since left.

Northwestern to pay $2.3 million for falsified research in NIH grants

Northwestern University Feinberg School of Medicine

A researcher accused of falsifying research in work funded by the National Institutes of Health has cost Northwestern University $2.3 million.

The university, based in Evanston, Ill., violated the Civil Monetary Penalties Law when a former researcher at the school falsified work funded by an NIH award, according to a November press release from the U.S. Department of Health & Human Services’ Office of Inspector General. The researcher and other investigators then referenced the falsified research in grant applications, reports and other submissions to NIH for two other awards, according to OIG. Together, the three grants totaled about $5 million, with $3.5 million tied to Northwestern.

The Civil Monetary Penalties law allows OIG to impose penalties against individuals and entities that engage in fraud and other improper conduct related to government grants. OIG learned of the researcher’s manipulation when Northwestern self-disclosed the conduct, the release said.

Sage journal retracts more than 40 papers over concerns with peer review, author contributions

Sage has retracted 45 papers from one of its journals for questionable authorship and peer review.

The publisher began an investigation into Clinical Hemorheology and Microcirculation last year to address citation concerns, a Sage spokesperson told Retraction Watch. The journal was one of 20 titles that lost their impact factors in Clarivate’s 2025 Journal Citation Reports for excessive self-citation and citation stacking.

Sage retracted the articles due to “concerns around the peer review process underlying these articles and author contributions to these articles, as well as the integrity of the research process,” according to the retraction notice, published November 23. The publisher detected “one or more” issues in each of the papers, including patterns of citation manipulation, indicators of third-party involvement and problems with peer review.

Court: University disclosure of researcher’s misconduct did not violate due process

An appellate court has dismissed a legal challenge by a cancer researcher against her former institution, ruling the university’s misconduct investigation and disclosure process did not violate her right to due process.

In 2020, The Ohio State University determined that Flavia Pichiorri, a former postdoc in the lab of Carlo Croce, was responsible for manipulating and reusing images in four publications, spanning from her time in Croce’s lab through establishing her own lab at Ohio State. Pichiorri sued the Ohio State Board of Trustees in April 2023 alleging the release of its misconduct findings to “prestigious journals” and her new employer violated her due process rights, defamed her, and inflicted emotional distress, among other claims.

But in a December 19 ruling, the U.S. Court of Appeals for the Sixth Circuit concluded Pichiorri’s complaint never identified an adequate “liberty interest” worthy of procedural protections under the Due Process Clause of the 14th Amendment. The appeals court affirmed a lower court’s decision tossing the complaint for failure to state a constitutional claim.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: